NLW Partners consults with treatment facilities and institutions of higher education on the best practices of addiction recovery, education, and research. President Dr. Kitty Harris, along with Chief Science Officer, Dr. Jared P. Dempsey are actively engaged in medical and behavioral research to assist in developing new technologies and solutions for companies seeking consolation services. NLW Partners also provide comprehensive statistical and neuroscientific consultation services.
Jared Dempsey Ph.D. and Kitty Harris Ph.D., are actively involved in research, education, and consultation. Their recent publications include preliminary evidence for a biological marker of addiction recovery utilizing functional near-infrared spectroscopy. By identifying a robust biological marker, we as a field will be better able to refine treatments and objectively track recovery at a neurological level.
Building Resilience for Students
AlphaPoint.Me addresses the core areas in a student’s life to promote resilience. The focus of this program revolves around substance use, mental health, diversity, relationships, and civility. AlphaPoint.Me is a 90-minute program for incoming students that assists colleges and universities in meeting Title IX, Clery Act, and EDGAR Part 86 requirements. Customizable interfaces, assessments, and content delivery provides a comprehensive approach for each school. The program utilizes an engaging online video series, including interactive modules, which optimize learning and behavior change. The content was created by a consortium of professors, scientists, and practitioners with direct experience working with collegiate populations. All of our experts have numerous peer-reviewed publications in their respective fields.
AlphaPoint.Solutions is an online sanction program for college students who experience difficulties with substance use, behaviors, or violation of school policy. The Solutions portfolio extends the AlphaPoint.Me series providing a science-based experiential tool. Our video-based Solutions program provides the necessary components for several critical areas including: Balance (alcohol and drugs), Relationships (sexual assault and harassment), and Diversity (inclusiveness and tolerance).
The opportunity to experience recovery from substance use disorders is now available in an electronically mediated and interactive format. We have three comprehensive online programs which provide early intervention, intensive treatment, and continuing care. These programs are in the process of becoming CARF accredited.
Dr. Kitty Harris Wilkes serves as President of NLW Partners, which is dedicated to consulting, education, science and research for addiction recovery. She is a noted author and public speaker, and presents at national conferences, workshops and seminars on topics including adolescence; collegiate addiction and recovery; and communication, civility and leadership.
Dr. Dempsey is the Chief Science Officer of NLW Partners. He holds a doctorate in clinical psychology, as well as a clinical residency and post-doctoral specialization in addiction science from the Medical University of South Carolina. He has published numerous peer-reviewed scientific articles on addiction and has served as an expert reviewer for some of the top addiction journals.
Amanda K. Baker, MS, LCDC is the Chief Clinical Officer at NLW Partners. She is also a Co-Founder and Clinical Director of Windhaven Counseling Center, LLC. In addition, she owns Mandy Baker Consulting, LLC where she works as a consultant to the addiction treatment industry specializing in compliance, risk management, quality management, administrative team building, and program/curriculum development.
Caleb is a student at Texas Tech University and his goal is pursuing a Ph.D. in Neuroscience. He is currently a laboratory manager at the Foundation for Recovery Initiatives and an executive assistant at NLW Partners. Caleb has extensive research in psychophysiology and neuroimaging research. He is also a named author on a peer-reviewed investigation detailing preliminary evidence for a biological marker of addiction recovery.